Simplify Logo

Full-Time

Manager – Statistical Programming

Posted on 2/22/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for gene targeting

Hardware
Biotechnology
Healthcare

Compensation Overview

$145k - $165kAnnually

Mid

Pasadena, CA, USA + 1 more

Category
Backend Engineering
Software QA & Testing
Software Engineering
Required Skills
SAP Products
Requirements
  • Master's degree in biostatistics/statistics/public health or similar field
  • At least 3 years' experience of statistical programming for clinical trials
  • Proficiency in SAS, including complex data manipulation, basic analysis procedures, SAS/MACRO, and SAS/GRAPH
  • Interest in career development as a leading role in statistical programming in pharmaceutical industry
  • Excellent verbal and written communication skills
Responsibilities
  • Develop targeted, study-specific SDTM and ADaM dataset checks
  • Perform independent QC, from raw data to ADaM, of primary and key secondary endpoints
  • Create draft output shells for ad-hoc requests, prepare analysis specs and scope
  • Deliver programming results for ad-hoc analysis requests
  • Review outputs provided by CROs for accuracy and consistency with the analysis plan and specs
  • Review and contribute to the development of study SAP
  • Collaborate with data management and their programming team to ensure appropriate data collection and reporting
  • Participate in study team meeting and support statistician operational activities
  • Assist in efforts to identify, develop, and implement departmental standards, applications, processes and training
  • Develop and manage the statistical programming team
  • Develop or support standard operation procedure preparation
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals specializes in developing RNAi-based therapies using their TRiM platform, which leverages various RNA chemistries for tissue-specific targeting, enabling rapid and durable knockdown of disease-causing genes. The TRiM platform also utilizes ligand-mediated delivery, offering potential advantages such as simplified manufacturing, reduced costs, and improved safety.

Company Stage

IPO

Total Funding

$899.9M

Headquarters

Pasadena, California

Founded

2004

INACTIVE